Dr. Agarwal's Health Care Limited: NCLT Sanctions Amalgamation Scheme
NCLT has sanctioned the amalgamation of Dr. Agarwal’s Eye Hospital Limited into Dr. Agarwal's Health Care Limited. The scheme is effective from April 01, 2026, and operative from the Effective Date, to be determined upon fulfillment of scheme conditions.
An approved amalgamation scheme is a significant corporate action that will fundamentally alter the company's structure and operations.
The NCLT sanctioning the amalgamation scheme is a positive step towards consolidating the business operations.
Dr. Agarwal's Health Care Limited (AHCL) has announced that the Hon’ble National Company Law Tribunal, Chennai Bench (NCLT), has sanctioned the Scheme of Amalgamation between Dr. Agarwal’s Eye Hospital Limited (AEHL) and AHCL, along with their respective shareholders and creditors. This scheme provides for the amalgamation of AEHL with and into AHCL.
The NCLT formally pronounced the Order sanctioning the scheme on September 30, 2026, with the order uploaded to the NCLT website on October 05, 2026. The certified copy of the Order is awaited and will be made available on the company's website upon receipt.
As per the Scheme and the NCLT Sanction Order dated September 30, 2026, the Scheme will be effective from the Appointed Date, which is April 01, 2026. It will become operative from the Effective Date, defined as the first day of the calendar month following the completion of all conditionalities mentioned in Clause 24 of the Scheme.
The company will continue to inform the stock exchanges about the effectiveness of the Scheme, the fixation of the Record Date, the allotment of shares as per the Share Exchange Ratio, and other subsequent developments.
What to do with a filing like this
Dr. Agarwal's Health Care Limited filed this with the NSE as a statutory disclosure, categorised under amalgamation. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Dr. Agarwal's Health Care Limited. Read the original for the full detail.